Insider · CIK 0001792062
Quoc Le-Nguyen
officer
Files at ETNB (89bio, Inc.). First filing Nov 1, 2024, latest Jul 17, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $505k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | 89bio, Inc. | $115k 10,461 shares | -3% | - | |
| 4Weak | 89bio, Inc. | $91k 15,329 shares | -4% | - | |
| 3Weak | 89bio, Inc. | $71k 10,963 shares | -4% | - | |
| 13Weak | 89bio, Inc. | $227k 27,955 shares | -13% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | ETNB 89bio, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 351,684 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stock | -351,684 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stockindirect: By Spouse | -13,694 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,063 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,312 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -67,500 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -120,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -195,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -320,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Spouse | -26,400 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Spouse | -17,500 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Aug 1, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -7,680 | $9.16 | $70k | 301,684 | Aug 5, 2025 |
| Aug 1, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stockindirect: By Spouse | -522 | $9.16 | $4,782 | 13,694 | Aug 5, 2025 |
| Jul 15, 2025 | ETNB 89bio, Inc. | SOpen-market sale Common Stock10b5-1 | -10,461 | $11.02 | $115k | 309,364 | Jul 17, 2025 |
| Jun 12, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -8,498 | $9.62 | $82k | 319,825 | Jun 13, 2025 |
| Jun 12, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stockindirect: By Spouse | -534 | $9.62 | $5,137 | 14,216 | Jun 13, 2025 |
| Apr 15, 2025 | ETNB 89bio, Inc. | SOpen-market sale Common Stock10b5-1 | -15,329 | $5.95 | $91k | 328,323 | Apr 17, 2025 |
| Dec 12, 2024 | ETNB 89bio, Inc. | AGrant or award Common Stockindirect: By Spouse | +6,000 | $0.00 | $0 | 6,000 | Feb 19, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Common Stockindirect: By Spouse | +8,750 | $9.60 | $84k | 14,750 | Feb 19, 2025 |
| Feb 17, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -1,050 | $10.57 | $11k | 343,652 | Feb 19, 2025 |
| Apr 2, 2024 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Spouse | +26,400 | $0.00 | $0 | 26,400 | Feb 19, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Spouse | +17,500 | $0.00 | $0 | 17,500 | Feb 19, 2025 |
| Feb 9, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -3,793 | $11.41 | $43k | 344,702 | Feb 11, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Common Stock | +80,000 | $0.00 | $0 | 351,833 | Feb 4, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -3,338 | $9.60 | $32k | 348,495 | Feb 4, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +320,000 | $0.00 | $0 | 320,000 | Feb 4, 2025 |
| Jan 15, 2025 | ETNB 89bio, Inc. | SOpen-market sale Common Stock10b5-1 | -10,963 | $6.49 | $71k | 271,833 | Jan 17, 2025 |
| Dec 12, 2024 | ETNB 89bio, Inc. | AGrant or award Common Stock | -95,000 | $0.00 | $0 | 282,796 | Dec 16, 2024 |
| Oct 30, 2024 | ETNB 89bio, Inc. | SOpen-market sale Common Stock10b5-1 | -27,955 | $8.12 | $227k | 187,796 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.